The interaction of PD-L1/PD-1 on activated T-cells impedes T-cell function and promotes CD4+ T cells’ differentiation into regulatory T-cells (Tregs), eventually protecting the tumor from immune-mediated rejection [12,13]. This evidence concerns the gene CD274 and neoplasm.